HARP

Harpoon Therapeutics, Inc. Common Stock
HARP

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

HARP was delisted on the 8th of March, 2024.

Back to rankings
 

About: Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.

Employees: 46

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™